Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment

Barry A. Borlaug, Walter J. Paulus

Research output: Contribution to journalReview article

624 Scopus citations

Abstract

Half of patients with heart failure (HF) have a preserved left ventricular ejection fraction (HFpEF). Morbidity and mortality in HFpEF are similar to values observed in patients with HF and reduced EF, yet no effective treatment has been identified. While early research focused on the importance of diastolic dysfunction in the pathophysiology of HFpEF, recent studies have revealed that multiple non-diastolic abnormalities in cardiovascular function also contribute. Diagnosis of HFpEF is frequently challenging and relies upon careful clinical evaluation, echo-Doppler cardiography, and invasive haemodynamic assessment. In this review, the principal mechanisms, diagnostic approaches, and clinical trials are reviewed, along with a discussion of novel treatment strategies that are currently under investigation or hold promise for the future.

Original languageEnglish (US)
Pages (from-to)670-679
Number of pages10
JournalEuropean heart journal
Volume32
Issue number6
DOIs
StatePublished - Mar 2011

Keywords

  • Diagnosis
  • Diastolic
  • Ejection fraction
  • Heart failure
  • Pathophysiology
  • Preserved ejection fraction
  • Systolic
  • Treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment'. Together they form a unique fingerprint.

  • Cite this